Press Releases May 13, 2026 10:02 AM

Eric Palmer Joins AMN Healthcare Board of Directors

AMN Healthcare strengthens leadership with addition of seasoned healthcare executive Eric Palmer to Board of Directors

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
AMN

AMN Healthcare announced the election of Eric Palmer, a seasoned healthcare executive with extensive leadership experience, to its Board of Directors effective May 1, 2026. Palmer's expertise in healthcare services, benefits, and insurance, along with his successful track record in scaling operations and managing large acquisitions, is expected to enhance AMN's governance and support its long-term growth strategy in healthcare workforce solutions.

Eric Palmer Joins AMN Healthcare Board of Directors
AMN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Eric Palmer appointed to AMN Healthcare Board of Directors effective May 1, 2026.
  • Palmer brings over 25 years of leadership in healthcare services, benefits, and insurance, including CEO roles and major acquisitions.
  • AMN Healthcare aims to leverage Palmer's expertise to strengthen governance and drive growth in healthcare workforce solutions and talent management.

DALLAS, May 13, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare, the leader and innovator in total talent solutions for healthcare organizations, announced the election of Eric Palmer to its Board of Directors, effective May 1, 2026.

Palmer is a seasoned healthcare executive with more than 25 years of leadership experience across healthcare services, benefits, and insurance industries. He has a strong track record of leading large-scale operations, driving strategic growth initiatives, and executing complex mergers, acquisitions, and divestitures.

“Eric’s extensive leadership experience, understanding of the healthcare ecosystem and alignment to our mission make him a valuable addition to our Board,” said Cary Grace, President and CEO of AMN Healthcare. “His proven ability to scale complex organizations and navigate dynamic market environments will strengthen our governance and support AMN’s long-term growth strategy.”

Palmer most recently served as Chief Executive Officer of Evernorth Health Services, where he led the organization’s growth to more than $200 billion in revenue, establishing it as a market leader in specialty pharmacy, pharmacy benefits, and care management services. Prior to that, he served as Chief Financial Officer of Cigna, where he played a central role in driving the transformational acquisition of Express Scripts, successfully combining two Fortune 100 companies.

“AMN’s commitment to empowering healthcare organizations and professionals deeply aligns with the work I’ve done throughout my career,” said Palmer. “I am honored to join the Board and am excited to support AMN’s mission to empower high-quality care through innovative workforce solutions.”

Palmer currently serves on the board of directors of LifeStance Health and is on the board of trustees of Kingswood-Oxford School and Connecticut Children’s Medical Center.

For more information about AMN Healthcare’s leadership team, please visit www.amnhealthcare.com.

About AMN Healthcare
AMN Healthcare is the leader and innovator in total talent solutions for healthcare, bringing together the people, processes and technology to deliver better care. Through a steadfast partnership approach, we solve the most pressing workforce challenges to enable better clinical outcomes and access to care. In 2025 our healthcare professionals reached more than 13 million patients at more than 2,300 healthcare systems, including 93 percent of the top healthcare systems nationwide. We provide a comprehensive network of quality healthcare professionals and deliver a fully integrated and customizable suite of workforce technologies.

Media Contact  
Corporate Communications  
AMN Healthcare  
AMN-PR@amnhealthcare.com  Investor Contact  
Randle Reece  
Senior Director, Investor Relations & Strategy  
AMN Healthcare  
(866) 861-3229 
ir@amnhealthcare.com 



Risks

  • Integration of new board members could lead to short-term strategic adjustments or internal realignments affecting execution.
  • External healthcare market uncertainties and regulatory changes may impact AMN Healthcare's growth plans and operations.
  • Competition in the healthcare staffing and workforce solutions sector remains strong, which could pressure AMN's market position despite leadership additions.

More from Press Releases

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026 Jun 14, 2026 Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026) Jun 14, 2026 Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Jun 14, 2026